Does ZOLMITRIPTAN Cause Product use in unapproved indication? 143 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 143 reports of Product use in unapproved indication have been filed in association with ZOLMITRIPTAN (Zolmitriptan). This represents 8.8% of all adverse event reports for ZOLMITRIPTAN.
143
Reports of Product use in unapproved indication with ZOLMITRIPTAN
8.8%
of all ZOLMITRIPTAN reports
23
Deaths
43
Hospitalizations
How Dangerous Is Product use in unapproved indication From ZOLMITRIPTAN?
Of the 143 reports, 23 (16.1%) resulted in death, 43 (30.1%) required hospitalization, and 9 (6.3%) were considered life-threatening.
Is Product use in unapproved indication Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ZOLMITRIPTAN. However, 143 reports have been filed with the FAERS database.
What Other Side Effects Does ZOLMITRIPTAN Cause?
Headache (335)
Drug ineffective (311)
Migraine (265)
Off label use (238)
Drug intolerance (204)
Nausea (181)
Hypersensitivity (148)
Dysphonia (138)
Swollen tongue (137)
Swelling face (134)
What Other Drugs Cause Product use in unapproved indication?
DUPILUMAB (33,452)
DICLOFENAC (12,197)
METHOTREXATE (8,930)
PREDNISONE (7,625)
RITUXIMAB (7,519)
MYCOPHENOLATE MOFETIL (5,910)
ACETAMINOPHEN (5,819)
CYCLOPHOSPHAMIDE (5,750)
RISPERIDONE (5,551)
TACROLIMUS (5,057)
Which ZOLMITRIPTAN Alternatives Have Lower Product use in unapproved indication Risk?
ZOLMITRIPTAN vs ZOLOFT
ZOLMITRIPTAN vs ZOLPIDEM
ZOLMITRIPTAN vs ZOLPIDEM\ZOLPIDEM
ZOLMITRIPTAN vs ZOMETA
ZOLMITRIPTAN vs ZONISAMIDE